DNA interactions of monofunctional organometallic ruthenium(II) antitumor complexes in cell-free medial

Biochemistry

Volumn 42, Issue 39, 2003, Pages 11544-11554

  Novakova, Olga ^a   Chen, Haimei ^b   Vrana, Oldrich ^a   Rodger, Alison ^c   Sadler, Peter J ^b   Brabec, Viktor ^a  

^a INSTITUTE OF BIOPHYSICS   (Czech Republic)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c UNIVERSITY OF WARWICK   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CELLS; COMPLEXATION; CONFORMATIONS; DNA; ORGANOMETALLICS; RUTHENIUM COMPOUNDS; SUBSTITUTION REACTIONS;

CELL-FREE MEDIAL;

BIOCHEMISTRY;

ANTHRACENE DERIVATIVE; BENZENE DERIVATIVE; BIPHENYLANTHRACENE; DIHYDROANTHRACENE; DNA; GUANINE; HYDROCARBON; INTERCALATING AGENT; MONODENTATE RUTHENIUM DERIVATIVE; ORGANOMETALLIC COMPOUND; PARA CYMENE; RUTHENIUM COMPLEX; TETRAHYDROANTHRACENE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; CELL FREE SYSTEM; CIRCULAR DICHROISM; CULTURE MEDIUM; DIFFERENTIAL PULSE POLAROGRAPHY; DNA BINDING; DNA CONFORMATION; DNA HELIX; DNA MODIFICATION; HYDROPHOBICITY; INTERCALATION COMPLEX; MELTING POINT; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN INTERACTION; THERMOSTABILITY;

ANIMALS; ANTINEOPLASTIC AGENTS; BASE SEQUENCE; BENZENE DERIVATIVES; CATTLE; DNA; DNA-DIRECTED RNA POLYMERASES; MOLECULAR SEQUENCE DATA; NUCLEIC ACID CONFORMATION; NUCLEIC ACID DENATURATION; ORGANOMETALLIC COMPOUNDS; ORGANOPLATINUM COMPOUNDS; PLASMIDS; POLYDEOXYRIBONUCLEOTIDES; RNA; RUTHENIUM; TEMPERATURE; VIRAL PROTEINS;

ARENE;

EID: 0141706614     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi034933u     Document Type: Article

References (55)

1. Johnson, N. P., Butour, J.-L., Villani, G., Wimmer, F. L., Defais, M., Pierson, V., and Brabec, V. (1989) Prog. Clin. Biochem. Med. 10, 1-24.
2. Brabec, V. (2000) in Platinum-Based Drugs in Cancer Therapy (Kelland, L. R., and Farrell, N. P., Eds.) pp 37-61, Humana Press Inc., Totowa, NJ.
3. Fichtinger-Schepman, A. M. J., Van der Veer, J. L., Den Hartog, J. H. J., Lohman, P. H. M., and Reedijk, J. (1985) Biochemistry 24, 707-713.
4. Eastman, A. (1987) Pharmacol. Ther. 34, 155-166.
5. Cleare, M. J. (1974) Coord. Chem. Rev. 12, 349-405.
6. Cleare, M. J. (1977) J. Clin. Hematol. Oncol. 7, 1-25.
7. Farrell, N. (1996) in Metal Ions in Biological Systems (Sigel, A., and Sigel, H., Eds.) pp 603-639, Marcel Dekker, Inc., New York, Basel, Hong Kong.
8. Brabec, V., Kasparkova, J., Vrana, O., Novakova, O., Cox, J. W., Qu, Y., and Farrell, N. (1999) Biochemistry 38, 6781-6790.
9. Farrell, N. (2000) in Platinum-Based Drugs in Cancer Therapy (Kelland, L. R., and Farrell, N. P., Eds.) pp 321-338, Humana Press Inc., Totowa, NJ.
10. Keppler, B. K. (1993) Metal Complexes in Cancer Chemotherapy, VCH Verlagsgesellschaft, VCH Publishers, Weinheim, New York.
11. Sava, G., and Bergamo, A. (2000) Int. J. Oncol. 17, 353-365.
12. Clarke, M. J. (2003) Coord. Chem. Rev. 236, 209-233.
13. Aird, R., Cummings, J., Ritchie, A., Muir, M., Morris, R., Chen, H., Sadler, P., and Jodrell, D. (2002) Br. J. Cancer 86, 1652-1657.
14. Morris, R. E., Aird, R. E., Murdoch, P. D., Chen, H. M., Cummings, J., Hughes, N. D., Parsons, S., Parkin, A., Boyd, G., Jodrell, D. I., and Sadler, P. J. (2001) J. Med. Chem. 44, 3616-3621.
15. Sava, G., Alessio, E., Bergano, A., and Mestroni, G. (1999) in Topics in Biological Inorganic Chemistry. Metallopharmaceuticals I (Clarke, M. J., and Sadler, P. J., Eds.) pp 143-169, Springer, Berlin.
16. Clarke, M. J., Zhu, F., and Frasca, D. R. (1999) Chem. Rev. 99, 2511-2533.
17. Sava, G., Pacor, S., Coluccia, M., Mariggio, M., Cocchietto, M., Alessio, E., and Mestroni, G. (1994) Drug Invest. 8, 150-161.
18. Novakova, O., Kasparkova, J., Vrana, O., van Vliet, P. M., Reedijk, J., and Brabec, V. (1995) Biochemistry 34, 12369-12378.
19. Barca, A., Pani, B., Tamaro, M., and Russo, E. (1999) Mutation Res. 423, 171-181.
20. Novakova, O., Hofr, C., and Brabec, V. (2000) Biochem. Pharmacol. 60, 1761-1771.
21. Malina, J., Novakova, O., Keppler, B. K., Alessio, E., and Brabec, V. (2001) J. Biol. Inorg. Chem. 6, 435-445.
22. Wang, F., Chen, H., Parsons, S., Oswald, I. D. H., Davidson, J. E., and Sadler, P. J. (2003) Chem. Eur. J., in press.
23. Chen, H. M., Parkinson, J. A., Morris, R. E., and Sadler, P. J. (2003) J. Am. Chem. Soc. 125, 173-186.
24. Brabec, V., and Palecek, E. (1970) Biophysik 6, 290-300.
25. Brabec, V., and Palecek, E. (1976) Biophys. Chem. 4, 76-92.
26. Lemaire, M. A., Schwartz, A., Rahmouni, A. R., and Leng, M. (1991) Proc. Natl. Acad. Sci. U.S.A. 88, 1982-1985.
27. Brabec, V., and Leng, M. (1993) Proc. Natl. Acad. Sci. U.S.A. 90, 5345-5349.
28. Keck, M. V., and Lippard, S. J. (1992) J. Am. Chem. Soc. 114, 3386-3390.
29. Butour, J. L., and Macquet, J. P. (1977) Eur. J. Biochem. 78, 455-463.
30. Butour, J. L., Alvinerie, P., Souchard, J. P., Colson, P., Houssier, C., and Johnson, N. P. (1991) Eur. J. Biochem. 202, 975-980.
31. Bancroft, D. P., Lepre, C. A., and Lippard, S. J. (1990) J. Am. Chem. Soc. 112, 6860-6871.
32. Brabec, V., Boudny, V., and Balcarova, Z. (1994) Biochemistry 33, 1316-1322.
33. Rodger, A., and Norden, B. (1997) Circular Dichroism and Linear Dichroism, Oxford University Press, Oxford, New York, Tokyo.
34. Jenkins, T. C. (1997) in Drug-DNA Interaction Protocols (Fox, K. R., Ed.) pp 195-218, Humana Press Inc., Totowa, NJ.
35. Marini, V., Kasparkova, J., Novakova, O., Scolaro, L. M., Romeo, R., and Brabec, V. (2002) J. Biol. Inorg. Chem. 7, 725-734.
36. Palecek, E. (1983) in Topics in Bioelectrochemistry and Bioenergetics (Milazzo, G., Ed.) pp 65-155, John Wiley and Sons, Ltd., New York.
37. Palecek, E. (1971) Methods Enzymol. 21, 3-24.
38. Brabec, V., Kleinwächter, V., Butour, J. L., and Johnson, N. P. (1990) Biophys. Chem. 35, 129-141.
39. Vrana, O., Kleinwächter, V., and Brabec, V. (1984) Experientia 40, 446-451.
40. Chen, H. M., Parkinson, J. A., Parsons, S., Coxall, R. A., Gould, R. O., and Sadler, P. J. (2002) J. Am. Chem. Soc. 124, 3064-3082.
41. Janiak, C. (2000) J. Chem. Soc., Dalton Trans., 3885-3896.
42. Stebler-Röthlisberger, M., Hummel, W., Pittet, P.-A., Bürgi, H.-B., Ludi, A., and Merbach, A. E. (1988) Inorg. Chem. 27, 1358-1363.
43. Long, E. C., and Barton, J. K. (1990) Acc. Chem. Res. 23, 271-273.
44. Lyng, R., Rodger, A., and Norden, B. (1991) Biopolymers 31, 1709-1720.
45. Arena, G., Monsu Scolaro, L., Pasternack, R. F., and Romeo, R. (1995) Inorg. Chem. 34, 2994-3002.
46. Maeda, Y., Nunomura, K., and Ohtsubo, E. (1990) J. Mol. Biol. 215, 321-329.
47. Bjorndal, M. T., and Fygenson, D. K. (2002) Biopolymers 65, 40-44.
48. Zaludova, R., Kleinwächter, V., and Brabec, V. (1996) Biophys. Chem. 60, 135-142.
49. Cohen, S. M., and Lippard, S. J. (2001) in Prog. Nucleic Acid Res. Mol. Biol. (Moldave, K., Ed.) pp 93-130, Academic Press Inc., San Diego, CA.
50. Brabec, V. (2002) in Prog. Nucleic Acid Res. Mol. Biol. (Moldave, K., Ed.) pp 1-68, Academic Press Inc., San Diego, CA.
51. Anin, M. F., and Leng, M. (1990) Nucleic Acids Res. 18, 4395-4400.
52. Gelasco, A., and Lippard, S. J. (1999) in Topics in Biological Inorganic Chemistry. Metallopharmaceuticals I (Clarke, M. J., and Sadler, P. J., Eds.) pp 1-43, Springer, Berlin.
53. Jamieson, E. R., and Lippard, S. J. (1999) Chem. Rev. 99, 2467-2498.
54. Zamble, D. B., Mu, D., Reardon, J. T., Sancar, A., and Lippard, S. J. (1996) Biochemistry 35, 10004-10013.
55. Brabec, V., and Kasparkova, J. (2002) Drug Resist. Updates 5, 147-161.